{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:36:24Z","timestamp":1793885784249,"version":"4.8.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015763","name":"Leukaemia UK","doi-asserted-by":"publisher","award":["2023\/JGF\/004"],"award-info":[{"award-number":["2023\/JGF\/004"]}],"id":[{"id":"10.13039\/100015763","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bneo.2025.100146","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T16:13:25Z","timestamp":1753460005000},"page":"100146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["How to drug a leukemic stem cell: deciphering heterogeneity for better specificity"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9419-2929","authenticated-orcid":false,"given":"Alice","family":"Worker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Jinks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2181-8370","authenticated-orcid":false,"given":"Peter","family":"Woodmancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2280-4045","authenticated-orcid":false,"given":"Claire","family":"Seedhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4011-7460","authenticated-orcid":false,"given":"Sophie G.","family":"Kellaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.bneo.2025.100146_bib1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.bneo.2025.100146_bib2","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.bneo.2025.100146_bib3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41571-021-00509-w","article-title":"Towards precision medicine for AML","volume":"18","author":"D\u00f6hner","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41588-018-0270-1","article-title":"Subtype-specific regulatory network rewiring in acute myeloid leukemia","volume":"51","author":"Assi","year":"2019","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.bneo.2025.100146_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113568","article-title":"Gene regulatory network analysis predicts cooperating transcription factor regulons required for FLT3-ITD+ AML growth","volume":"42","author":"Coleman","year":"2023","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.bneo.2025.100146_bib6","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ccell.2018.08.014","article-title":"Prospective isolation and characterization of genetically and functionally distinct AML subclones","volume":"34","author":"de Boer","year":"2018","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.bneo.2025.100146_bib7","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/ng.3646","article-title":"Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution","volume":"48","author":"Corces","year":"2016","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.bneo.2025.100146_bib8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.bneo.2025.100146_bib9","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s41375-018-0326-3","article-title":"CD34+CD38- leukemic stem cell frequency to predict outcome in acute myeloid leukemia","volume":"33","author":"Zeijlemaker","year":"2019","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.bneo.2025.100146_bib10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ajh.24663","article-title":"Prognostic impact of the CD34+\/CD38- cell burden in patients with acute myeloid leukemia receiving allogeneic stem cell transplantation","volume":"92","author":"Jentzsch","year":"2017","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1016\/j.bneo.2025.100146_bib11","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1038\/s41375-021-01295-1","article-title":"Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeq","volume":"35","author":"Saygin","year":"2021","journal-title":"Leukemia"},{"issue":"18","key":"10.1016\/j.bneo.2025.100146_bib12","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.1158\/1078-0432.CCR-05-0468","article-title":"High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival","volume":"11","author":"van Rhenen","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"6464","key":"10.1016\/j.bneo.2025.100146_bib13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bneo.2025.100146_bib14","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1182\/blood-2009-02-206565","article-title":"Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction","volume":"115","author":"Taussig","year":"2010","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bneo.2025.100146_bib15","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1084\/jem.20151775","article-title":"Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage","volume":"213","author":"Quek","year":"2016","journal-title":"J Exp Med"},{"issue":"7633","key":"10.1016\/j.bneo.2025.100146_bib16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature20598","article-title":"A 17-gene stemness score for rapid determination of risk in acute leukaemia","volume":"540","author":"Ng","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bneo.2025.100146_bib17","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1182\/blood-2007-10-118331","article-title":"Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells","volume":"112","author":"Taussig","year":"2008","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bneo.2025.100146_bib18","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1182\/blood.V89.9.3104","article-title":"Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo","volume":"89","author":"Blair","year":"1997","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bneo.2025.100146_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2141.2004.04883.x","article-title":"CD90\/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias","volume":"125","author":"Buccisano","year":"2004","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.bneo.2025.100146_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/bjh.13941","article-title":"CD45RA, a specific marker for leukaemia stem cell sub-populations in acute myeloid leukaemia","volume":"173","author":"Kersten","year":"2016","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.bneo.2025.100146_bib21","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1073\/pnas.1100551108","article-title":"Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker","volume":"108","author":"Jan","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"10.1016\/j.bneo.2025.100146_bib22","doi-asserted-by":"crossref","first-page":"11008","DOI":"10.1073\/pnas.0704271104","article-title":"CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia","volume":"104","author":"Hosen","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.bneo.2025.100146_bib23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","article-title":"CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells","volume":"138","author":"Majeti","year":"2009","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ccr.2010.12.012","article-title":"Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia","volume":"19","author":"Goardon","year":"2011","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.bneo.2025.100146_bib25","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1038\/s41375-024-02358-9","article-title":"Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties","volume":"38","author":"Boutzen","year":"2024","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.bneo.2025.100146_bib26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/life14030309","article-title":"Recent advances towards the understanding of secondary acute myeloid leukemia progression","volume":"14","author":"Auerbach","year":"2024","journal-title":"Life"},{"issue":"149","key":"10.1016\/j.bneo.2025.100146_bib27","doi-asserted-by":"crossref","first-page":"149ra118","DOI":"10.1126\/scitranslmed.3004315","article-title":"Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia","volume":"4","author":"Jan","year":"2012","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.bneo.2025.100146_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3904\/kjim.2020.014","article-title":"Leukemic stem cell phenotype is associated with mutational profile in acute myeloid leukemia","volume":"36","author":"Han","year":"2021","journal-title":"Korean J Intern Med"},{"issue":"12","key":"10.1016\/j.bneo.2025.100146_bib29","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.3324\/haematol.2019.226282","article-title":"Plasticity in growth behavior of patients' acute myeloid leukemia stem cells growing in mice","volume":"105","author":"Ebinger","year":"2020","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.bneo.2025.100146_bib30","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ccell.2018.08.007","article-title":"Identification of chemotherapy-induced leukemic-regenerating cells reveals a transient vulnerability of human AML recurrence","volume":"34","author":"Boyd","year":"2018","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.bneo.2025.100146_bib31","article-title":"Identification of cells of leukemic stem cell origin with non-canonical regenerative properties","volume":"5","author":"Hollands","year":"2024","journal-title":"Cell Rep Med"},{"issue":"3","key":"10.1016\/j.bneo.2025.100146_bib32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","article-title":"BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells","volume":"12","author":"Lagadinou","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib33","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1038\/s41467-025-58370-9","article-title":"Epigenetic mechanisms controlling human leukemia stem cells and therapy resistance","volume":"16","author":"Takao","year":"2025","journal-title":"Nat Commun"},{"issue":"7661","key":"10.1016\/j.bneo.2025.100146_bib34","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature22993","article-title":"Tracing the origins of relapse in acute myeloid leukaemia to stem cells","volume":"547","author":"Shlush","year":"2017","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bneo.2025.100146_bib35","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1182\/blood.2021014604","article-title":"An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study","volume":"140","author":"Li","year":"2022","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.bneo.2025.100146_bib36","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1182\/blood-2015-12-689356","article-title":"inv(16) and NPM1mut AMLs engraft human cytokine knock-in mice","volume":"128","author":"Ellegast","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bneo.2025.100146_bib37","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3324\/haematol.2016.153528","article-title":"Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice","volume":"102","author":"Paczulla","year":"2017","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.bneo.2025.100146_bib38","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1182\/blood-2005-06-2325","article-title":"AML engraftment in the NOD\/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML","volume":"107","author":"Pearce","year":"2006","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bneo.2025.100146_bib39","article-title":"Leukemic progenitor compartment serves as a prognostic measure of cancer stemness in patients with acute myeloid leukemia","volume":"4","author":"Boyd","year":"2023","journal-title":"Cell Rep Med"},{"issue":"6","key":"10.1016\/j.bneo.2025.100146_bib40","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity","volume":"176","author":"van Galen","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib41","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/s41467-024-45737-7","article-title":"Cellular hierarchy insights reveal leukemic stem-like cells and early death risk in acute promyelocytic leukemia","volume":"15","author":"Jin","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib42","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1038\/s41467-019-11591-1","article-title":"A general approach for detecting expressed mutations in AML cells using single cell RNA-sequencing","volume":"10","author":"Petti","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib43","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/s41467-021-21650-1","article-title":"Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics","volume":"12","author":"Velten","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.bneo.2025.100146_bib44","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41591-022-01819-x","article-title":"A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia","volume":"28","author":"Zeng","year":"2022","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.bneo.2025.100146_bib45","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.stem.2023.04.001","article-title":"Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemia","volume":"30","author":"Beneyto-Calabuig","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib46","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41467-024-45691-4","article-title":"Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth","volume":"15","author":"Kellaway","year":"2024","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.bneo.2025.100146_bib47","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1158\/2643-3230.BCD-24-0342","article-title":"Single-cell transcriptional atlas of human hematopoiesis reveals genetic and hierarchy-based determinants of aberrant AML differentiation","volume":"6","author":"Zeng","year":"2025","journal-title":"Blood Cancer Discov"},{"issue":"8","key":"10.1016\/j.bneo.2025.100146_bib48","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1158\/0008-5472.CAN-15-2063","article-title":"Frequency and dynamics of leukemia-initiating cells during short-term ex vivo culture informs outcomes in acute myeloid leukemia patients","volume":"76","author":"Griessinger","year":"2016","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.bneo.2025.100146_bib49","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/s41588-022-01179-9","article-title":"Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation","volume":"54","author":"Nam","year":"2022","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.bneo.2025.100146_bib50","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nm.2415","article-title":"Stem cell gene expression programs influence clinical outcome in human leukemia","volume":"17","author":"Eppert","year":"2011","journal-title":"Nat Med"},{"issue":"24","key":"10.1016\/j.bneo.2025.100146_bib51","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1001\/jama.2010.1862","article-title":"Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia","volume":"304","author":"Gentles","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib52","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1038\/s41467-022-33244-6","article-title":"Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia","volume":"13","author":"Huang","year":"2022","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.bneo.2025.100146_bib53","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41375-019-0604-8","article-title":"A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia","volume":"34","author":"Elsayed","year":"2020","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib54","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41698-024-00643-5","article-title":"Integrated drug resistance and leukemic stemness gene-expression scores predict outcomes in large cohort of over 3500 AML patients from 10 trials","volume":"8","author":"H Elsayed","year":"2024","journal-title":"NPJ Precis Oncol"},{"issue":"2","key":"10.1016\/j.bneo.2025.100146_bib67","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41375-023-02118-1","article-title":"Gene regulation in t(6;9) DEK::NUP214 acute myeloid leukemia resembles that of FLT3-ITD\/NPM1 acute myeloid leukemia but with an altered HOX\/MEIS axis","volume":"38","author":"Potluri","year":"2024","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.bneo.2025.100146_bib68","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.ccell.2023.10.008","article-title":"A longitudinal single-cell atlas of treatment response in pediatric AML","volume":"41","author":"Lambo","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib69","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12943-022-01635-4","article-title":"Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemia","volume":"21","author":"Zhai","year":"2022","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib70","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/s41467-023-36969-0","article-title":"Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia","volume":"14","author":"Naldini","year":"2023","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.bneo.2025.100146_bib55","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1182\/blood-2015-07-655928","article-title":"Increased DNA methylation of Dnmt3b targets impairs leukemogenesis","volume":"127","author":"Schulze","year":"2016","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bneo.2025.100146_bib56","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.stem.2024.06.007","article-title":"Nynrin preserves hematopoietic stem cell function by inhibiting the mitochondrial permeability transition pore opening","volume":"31","author":"Zhou","year":"2024","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.bneo.2025.100146_bib57","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s12185-012-1115-9","article-title":"FLT3-ITD-associated gene-expression signatures in NPM1-mutated cytogenetically normal acute myeloid leukemia","volume":"96","author":"Huang","year":"2012","journal-title":"Int J Hematol"},{"issue":"2","key":"10.1016\/j.bneo.2025.100146_bib58","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00277-020-04358-y","article-title":"Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125","volume":"100","author":"Wang","year":"2021","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib59","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1182\/blood-2014-06-584417","article-title":"CDK6 as a key regulator of hematopoietic and leukemic stem cell activation","volume":"125","author":"Scheicher","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bneo.2025.100146_bib60","article-title":"CDK6 is a potential prognostic biomarker in acute myeloid leukemia","volume":"11","author":"Liu","year":"2020","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib61","doi-asserted-by":"crossref","first-page":"9139","DOI":"10.1038\/s41598-019-45579-0","article-title":"SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness","volume":"9","author":"Nguyen","year":"2019","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.bneo.2025.100146_bib62","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1158\/0008-5472.CAN-14-3625","article-title":"SOCS2 controls proliferation and stemness of hematopoietic cells under stress conditions and its deregulation marks unfavorable acute leukemias","volume":"75","author":"Vitali","year":"2015","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib63","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41390-024-03341-x","article-title":"Acute myeloid leukemia stem cell signature gene EMP1 is not an eligible therapeutic target","volume":"97","author":"Van Camp","year":"2025","journal-title":"Pediatr Res"},{"issue":"5","key":"10.1016\/j.bneo.2025.100146_bib64","article-title":"CD34-structure, functions and relationship with cancer stem cells","volume":"59","author":"Radu","year":"2023","journal-title":"Medicina (Kaunas)"},{"issue":"8","key":"10.1016\/j.bneo.2025.100146_bib65","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1038\/leu.2016.76","article-title":"GPR56 contributes to the development of acute myeloid leukemia in mice","volume":"30","author":"Daria","year":"2016","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.bneo.2025.100146_bib66","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/leu.2013.75","article-title":"Maintenance of the hematopoietic stem cell pool in bone marrow niches by EVI1-regulated GPR56","volume":"27","author":"Saito","year":"2013","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.bneo.2025.100146_bib71","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1038\/s41375-022-01719-6","article-title":"Autophagy inhibition impairs leukemia stem cell function in FLT3-ITD AML but has antagonistic interactions with tyrosine kinase inhibition","volume":"36","author":"Qiu","year":"2022","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.bneo.2025.100146_bib72","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.leu.2401903","article-title":"The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells","volume":"14","author":"Jordan","year":"2000","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.bneo.2025.100146_bib73","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1158\/2159-8290.CD-22-1396","article-title":"Distinct assemblies of heterodimeric cytokine receptors govern stemness programs in leukemia","volume":"13","author":"Kan","year":"2023","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib74","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41408-024-01144-1","article-title":"Multiomic analysis identifies a high-risk subgroup that predicts poor prognosis in t(8;21) acute myeloid leukemia","volume":"14","author":"Liu","year":"2024","journal-title":"Blood Cancer J"},{"issue":"7","key":"10.1016\/j.bneo.2025.100146_bib75","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1182\/blood.2021012778","article-title":"PLCG1 is required for AML1-ETO leukemia stem cell self-renewal","volume":"139","author":"Schnoeder","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib76","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/bjh.19107","article-title":"Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia","volume":"204","author":"de Castro","year":"2024","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib77","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1038\/s41598-017-07356-9","article-title":"Suppression of transposable elements in leukemic stem cells","volume":"7","author":"Colombo","year":"2017","journal-title":"Sci Rep"},{"issue":"7498","key":"10.1016\/j.bneo.2025.100146_bib78","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature13035","article-title":"Haematopoietic stem cells require a highly regulated protein synthesis rate","volume":"509","author":"Signer","year":"2014","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.bneo.2025.100146_bib79","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1101\/gad.282756.116","article-title":"The rate of protein synthesis in hematopoietic stem cells is limited partly by 4E-BPs","volume":"30","author":"Signer","year":"2016","journal-title":"Genes Dev"},{"key":"10.1016\/j.bneo.2025.100146_bib80","article-title":"CD99 promotes self-renewal in hematopoietic stem cells and leukemia stem cells by regulating protein synthesis","author":"Huang","year":"2023","journal-title":"bioRxiv"},{"issue":"11","key":"10.1016\/j.bneo.2025.100146_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114864","article-title":"Defective ribosome assembly impairs leukemia progression in a murine model of acute myeloid leukemia","volume":"43","author":"Sj\u00f6vall","year":"2024","journal-title":"Cell Rep"},{"issue":"7","key":"10.1016\/j.bneo.2025.100146_bib82","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.3324\/haematol.2019.220962","article-title":"Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group","volume":"105","author":"Aplenc","year":"2020","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib83","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13045-023-01476-8","article-title":"A phase 1\/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents","volume":"16","author":"Short","year":"2023","journal-title":"J Hematol Oncol"},{"issue":"13","key":"10.1016\/j.bneo.2025.100146_bib84","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood-2017-09-805895","article-title":"Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML","volume":"131","author":"Swords","year":"2018","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.bneo.2025.100146_bib85","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1158\/0008-5472.CAN-23-2314","article-title":"Adhesion GPCR ADGRE2 maintains proteostasis to promote progression in acute myeloid leukemia","volume":"84","author":"Huang","year":"2024","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.bneo.2025.100146_bib86","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41556-019-0285-6","article-title":"Adaptive endoplasmic reticulum stress signalling via IRE1\u03b1-XBP1 preserves self-renewal of haematopoietic and pre-leukaemic stem cells","volume":"21","author":"Liu","year":"2019","journal-title":"Nat Cell Biol"},{"issue":"7504","key":"10.1016\/j.bneo.2025.100146_bib87","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nature13228","article-title":"The unfolded protein response governs integrity of the haematopoietic stem-cell pool during stress","volume":"510","author":"van Galen","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib88","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.celrep.2019.12.003","article-title":"Modest declines in proteome quality impair hematopoietic stem cell self-renewal","volume":"30","author":"Hidalgo","year":"2020","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.bneo.2025.100146_bib89","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.stem.2023.02.010","article-title":"Hematopoietic stem cells preferentially traffic misfolded proteins to aggresomes and depend on aggrephagy to maintain protein homeostasis","volume":"30","author":"Chua","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.bneo.2025.100146_bib90","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/leu.2016.329","article-title":"JUN is a key transcriptional regulator of the unfolded protein response in acute myeloid leukemia","volume":"31","author":"Zhou","year":"2017","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.bneo.2025.100146_bib91","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3324\/haematol.2023.282691","article-title":"DNAJC10 maintains survival and self-renewal of leukemia stem cells through PERK branch of the unfolded protein response","volume":"109","author":"Li","year":"2024","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib92","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1038\/s41467-022-33861-1","article-title":"HSF1 is a driver of leukemia stem cell self-renewal in acute myeloid leukemia","volume":"13","author":"Dong","year":"2022","journal-title":"Nat Commun"},{"issue":"33","key":"10.1016\/j.bneo.2025.100146_bib93","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1038\/onc.2014.364","article-title":"Cks1 is a critical regulator of hematopoietic stem cell quiescence and cycling, operating upstream of Cdk inhibitors","volume":"34","author":"Tomiatti","year":"2015","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.bneo.2025.100146_bib94","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000853","article-title":"The CKS1\/CKS2 proteostasis axis is crucial to maintain hematopoietic stem cell function","volume":"7","author":"Grey","year":"2023","journal-title":"Hemasphere"},{"issue":"650","key":"10.1016\/j.bneo.2025.100146_bib95","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn3248","article-title":"CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemia","volume":"14","author":"Grey","year":"2022","journal-title":"Sci Transl Med"},{"issue":"11","key":"10.1016\/j.bneo.2025.100146_bib96","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.stem.2023.09.013","article-title":"Hematopoietic stem cells through the ages: a lifetime of adaptation to organismal demands","volume":"30","author":"Kasbekar","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.bneo.2025.100146_bib97","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.devcel.2020.06.029","article-title":"Hematopoietic stem cell metabolism during development and aging","volume":"54","author":"Nakamura-Ishizu","year":"2020","journal-title":"Dev Cell"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib98","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/13510002.2022.2046423","article-title":"Role of mitochondrial reactive oxygen species in homeostasis regulation","volume":"27","author":"Zhang","year":"2022","journal-title":"Redox Rep"},{"issue":"5","key":"10.1016\/j.bneo.2025.100146_bib99","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","article-title":"Inhibition of amino Acid metabolism selectively targets human leukemia stem cells","volume":"34","author":"Jones","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.celrep.2019.03.009","article-title":"The hematopoietic oxidase NOX2 regulates self-renewal of leukemic stem cells","volume":"27","author":"Adane","year":"2019","journal-title":"Cell Rep"},{"issue":"11","key":"10.1016\/j.bneo.2025.100146_bib101","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1182\/blood.2019001808","article-title":"Aldehyde dehydrogenase 3a2 protects AML cells from oxidative death and the synthetic lethality of ferroptosis inducers","volume":"136","author":"Yusuf","year":"2020","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bneo.2025.100146_bib102","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2007-05-092510","article-title":"Internal tandem duplication of FLT3 (FLT3\/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML","volume":"111","author":"Sallmyr","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bneo.2025.100146_bib103","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/leu.2010.263","article-title":"NADPH oxidases regulate cell growth and migration in myeloid cells transformed by oncogenic tyrosine kinases","volume":"25","author":"Reddy","year":"2011","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.bneo.2025.100146_bib104","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13059-023-03031-7","article-title":"Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML","volume":"24","author":"Zhang","year":"2023","journal-title":"Genome Biol"},{"issue":"3","key":"10.1016\/j.bneo.2025.100146_bib106","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41556-024-01349-3","article-title":"SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming","volume":"26","author":"Xu","year":"2024","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.bneo.2025.100146_bib107","first-page":"5","article-title":"Reactive oxygen species and its role in pathogenesis and resistance to therapy in acute myeloid leukemia","volume":"7","author":"Khorashad","year":"2024","journal-title":"Cancer Drug Resist"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41375-021-01416-w","article-title":"Mitochondrial metabolism as a potential therapeutic target in myeloid leukaemia","volume":"36","author":"de Beauchamp","year":"2022","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.bneo.2025.100146_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105555","article-title":"Involvement of ORAI1\/SOCE in human AML cell lines and primary cells according to ABCB1 activity, LSC compartment and potential resistance to Ara-C exposure","volume":"23","author":"Lewuillon","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.bneo.2025.100146_bib110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.exphem.2007.11.014","article-title":"MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia","volume":"36","author":"Ho","year":"2008","journal-title":"Exp Hematol"},{"issue":"5","key":"10.1016\/j.bneo.2025.100146_bib111","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/ejh.12938","article-title":"MRP1 protein expression in leukemic stem cells as a negative prognostic marker in acute myeloid leukemia patients","volume":"99","author":"Paprocka","year":"2017","journal-title":"Eur J Haematol"},{"issue":"6","key":"10.1016\/j.bneo.2025.100146_bib112","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1158\/1078-0432.CCR-04-0212","article-title":"Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia","volume":"11","author":"Raaijmakers","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.bneo.2025.100146_bib113","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1080\/10428194.2018.1434884","article-title":"Quantitative assessment of the sensitivity of dormant AML cells to the BAD mimetics ABT-199 and ABT-737","volume":"59","author":"Yu","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.bneo.2025.100146_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.bneo.2024.100017","article-title":"Real-world outcomes of newly diagnosed AML treated with venetoclax and azacitidine or low-dose cytarabine in the UK NHS","volume":"1","author":"Othman","year":"2024","journal-title":"Blood Neoplasia"},{"issue":"7","key":"10.1016\/j.bneo.2025.100146_bib115","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and venetoclax in previously untreated acute myeloid leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.bneo.2025.100146_bib116","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","article-title":"Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia","volume":"24","author":"Pollyea","year":"2018","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.bneo.2025.100146_bib117","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/2159-8290.CD-22-0939","article-title":"Combinatorial BCL2 family expression in acute myeloid leukemia stem cells predicts clinical response to azacitidine\/venetoclax","volume":"13","author":"Waclawiczek","year":"2023","journal-title":"Cancer Discov"},{"issue":"3","key":"10.1016\/j.bneo.2025.100146_bib118","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3324\/haematol.2020.252569","article-title":"Outcomes of relapsed or refractory acute myeloid leukemia after frontline hypomethylating agent and venetoclax regimens","volume":"106","author":"Maiti","year":"2021","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.bneo.2025.100146_bib119","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/2159-8290.CD-19-0125","article-title":"The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells","volume":"9","author":"Nechiporuk","year":"2019","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.bneo.2025.100146_bib120","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1182\/blood.2022016090","article-title":"Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia","volume":"141","author":"Moujalled","year":"2023","journal-title":"Blood"},{"issue":"8041","key":"10.1016\/j.bneo.2025.100146_bib121","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41586-024-08137-x","article-title":"RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax","volume":"636","author":"Sango","year":"2024","journal-title":"Nature"},{"issue":"516","key":"10.1016\/j.bneo.2025.100146_bib122","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax2863","article-title":"Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress response","volume":"11","author":"Sharon","year":"2019","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.bneo.2025.100146_bib123","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41419-024-06995-x","article-title":"CRISPR screen of venetoclax response-associated genes identifies transcription factor ZNF740 as a key functional regulator","volume":"15","author":"Zhang","year":"2024","journal-title":"Cell Death Dis"},{"issue":"5","key":"10.1016\/j.bneo.2025.100146_bib124","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/s41375-023-01879-z","article-title":"Targeting a mitochondrial E3 ubiquitin ligase complex to overcome AML cell-intrinsic venetoclax resistance","volume":"37","author":"Nakao","year":"2023","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.bneo.2025.100146_bib125","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1158\/2159-8290.CD-20-1851","article-title":"An in vivo CRISPR screening platform for prioritizing therapeutic targets in AML","volume":"12","author":"Lin","year":"2022","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib126","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13045-021-01076-4","article-title":"Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine","volume":"14","author":"Buettner","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"5","key":"10.1016\/j.bneo.2025.100146_bib127","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/ejh.13492","article-title":"Pairing MCL-1 inhibition with venetoclax improves therapeutic efficiency of BH3-mimetics in AML","volume":"105","author":"Hormi","year":"2020","journal-title":"Eur J Haematol"},{"issue":"12","key":"10.1016\/j.bneo.2025.100146_bib128","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1158\/2159-8290.CD-18-0140","article-title":"A novel MCL1 inhibitor combined with venetoclax rescues venetoclax-resistant acute myelogenous leukemia","volume":"8","author":"Ramsey","year":"2018","journal-title":"Cancer Discov"},{"issue":"102","key":"10.1016\/j.bneo.2025.100146_bib129","doi-asserted-by":"crossref","first-page":"37777","DOI":"10.18632\/oncotarget.26540","article-title":"Genetic biomarkers predict response to dual BCL-2 and MCL-1 targeting in acute myeloid leukaemia cells","volume":"9","author":"Grundy","year":"2018","journal-title":"Oncotarget"},{"issue":"20","key":"10.1016\/j.bneo.2025.100146_bib130","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1182\/blood.2020010167","article-title":"Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias","volume":"137","author":"Thijssen","year":"2021","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bneo.2025.100146_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087180","article-title":"Synergistic action of MCL-1 inhibitor with BCL-2\/BCL-XL or MAPK pathway inhibitors enhances acute myeloid leukemia cell apoptosis and differentiation","volume":"24","author":"Opydo","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"21","key":"10.1016\/j.bneo.2025.100146_bib132","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1158\/1078-0432.CCR-24-0028","article-title":"A phase 1 first-in-human study of the MCL-1 inhibitor AZD5991 in patients with relapsed\/refractory hematologic malignancies","volume":"30","author":"Desai","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.bneo.2025.100146_bib133","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41419-025-07560-w","article-title":"Targeting METTL3 mitigates venetoclax resistance via proteasome-mediated modulation of MCL1 in acute myeloid leukemia","volume":"16","author":"Jiao","year":"2025","journal-title":"Cell Death Dis"},{"issue":"7860","key":"10.1016\/j.bneo.2025.100146_bib134","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bneo.2025.100146_bib135","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/2159-8290.CD-19-0710","article-title":"Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia","volume":"10","author":"Pei","year":"2020","journal-title":"Cancer Discov"},{"issue":"12","key":"10.1016\/j.bneo.2025.100146_bib136","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1038\/s41588-024-01999-x","article-title":"Single-cell multiomics analysis reveals dynamic clonal evolution and targetable phenotypes in acute myeloid leukemia with complex karyotype","volume":"56","author":"Lepp\u00e4","year":"2024","journal-title":"Nat Genet"},{"issue":"24","key":"10.1016\/j.bneo.2025.100146_bib137","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1182\/bloodadvances.2019000540","article-title":"Retinoic acid synergizes with the unfolded protein response and oxidative stress to induce cell death in FLT3-ITD+ AML","volume":"3","author":"Masciarelli","year":"2019","journal-title":"Blood Adv"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328025000810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328025000810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T01:41:21Z","timestamp":1764121281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950328025000810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":137,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2950328025000810"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2025.100146","relation":{},"ISSN":["2950-3280"],"issn-type":[{"value":"2950-3280","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to drug a leukemic stem cell: deciphering heterogeneity for better specificity","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2025.100146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society of Hematology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100146"}}